Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

This study has been completed.
Watson Laboratories, Inc.
Information provided by:
Kremers Urban Development Company Identifier:
First received: December 23, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)